Polycystic Ovary Syndrome Is Associated with an Increased Prevalence of Irritable Bowel Syndrome

[1] Azziz R(2004)Androgen excess in women: experience with over 1,000 consecutive patients J Clin Endocrinol Metab 89 453-462

[2] Sanchez LA(1986)Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism Br Med J (Clin Res Ed) 293 355-359

[3] Knochenhauer ES(2006)Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature J Clin Endocrinol Metab 91 781-785

[4] Moran C(2005)Polycystic ovary syndrome N Engl J Med 352 1223-1236

[5] Lazenby J(2008)Impact of obesity on the risk for polycystic ovary syndrome J Clin Endocrinol Metab 93 162-168

[6] Stephens KC(1992)Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome Clin Endocrinol (Oxf) 36 105-111

[7] Taylor K(2008)Metabolic and cardiovascular consequences of polycystic ovary syndrome Minerva Ginecol 60 39-51

[8] Boots LR(2001)Low grade chronic inflammation in women with polycystic ovarian syndrome J Clin Endocrinol Metab 86 2453-2455

[9] Adams J(1987)Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia J Clin Endocrinol Metab 65 499-507

[10] Polson DW(2004)Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria Gastroentérologie clinique et biologique 28 554-561

[1] Azziz R(2004)Androgen excess in women: experience with over 1,000 consecutive patients J Clin Endocrinol Metab 89 453-462

[2] Sanchez LA(1986)Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism Br Med J (Clin Res Ed) 293 355-359

[3] Knochenhauer ES(2006)Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature J Clin Endocrinol Metab 91 781-785

[4] Moran C(2005)Polycystic ovary syndrome N Engl J Med 352 1223-1236

[5] Lazenby J(2008)Impact of obesity on the risk for polycystic ovary syndrome J Clin Endocrinol Metab 93 162-168

[6] Stephens KC(1992)Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome Clin Endocrinol (Oxf) 36 105-111

[7] Taylor K(2008)Metabolic and cardiovascular consequences of polycystic ovary syndrome Minerva Ginecol 60 39-51

[8] Boots LR(2001)Low grade chronic inflammation in women with polycystic ovarian syndrome J Clin Endocrinol Metab 86 2453-2455

[9] Adams J(1987)Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia J Clin Endocrinol Metab 65 499-507

[10] Polson DW(2004)Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria Gastroentérologie clinique et biologique 28 554-561